MeiraGTx Holdings plc (MGTX)
NASDAQ: MGTX · Real-Time Price · USD
5.93
+0.01 (0.17%)
At close: Nov 22, 2024, 4:00 PM
6.00
+0.07 (1.18%)
After-hours: Nov 22, 2024, 6:11 PM EST

MeiraGTx Holdings Revenue

MeiraGTx Holdings had revenue of $10.91M in the quarter ending September 30, 2024, with 113.80% growth. This brings the company's revenue in the last twelve months to $13.93M, up 108.24% year-over-year. In the year 2023, MeiraGTx Holdings had annual revenue of $14.02M, down -11.95%.

Revenue (ttm)
$13.93M
Revenue Growth
+108.24%
P/S Ratio
27.93
Revenue / Employee
$32,774
Employees
425
Market Cap
463.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.02M-1.90M-11.95%
Dec 31, 202215.92M-21.78M-57.77%
Dec 31, 202137.70M22.14M142.25%
Dec 31, 202015.56M2.27M17.09%
Dec 31, 201913.29M--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xeris Biopharma Holdings 187.36M
SIGA Technologies 173.73M
Rigel Pharmaceuticals 157.37M
Y-mAbs Therapeutics 84.55M
REGENXBIO 84.33M
Theravance Biopharma 63.19M
Semler Scientific 58.94M
OmniAb 20.41M
Revenue Rankings